NeuroMetrix, Inc.

MUN:NLZ0 株式レポート

時価総額:€7.4m

NeuroMetrix 過去の業績

過去 基準チェック /06

NeuroMetrix's earnings have been declining at an average annual rate of -16.3%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been declining at an average rate of 11.3% per year.

主要情報

-16.3%

収益成長率

51.8%

EPS成長率

Medical Equipment 業界の成長4.3%
収益成長率-11.3%
株主資本利益率-45.8%
ネット・マージン-181.0%
前回の決算情報30 Jun 2024

最近の業績更新

Recent updates

収支内訳

NeuroMetrix の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

MUN:NLZ0 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Jun 244-892
31 Mar 245-893
31 Dec 236-793
30 Sep 236-682
30 Jun 237-583
31 Mar 238-583
31 Dec 228-473
30 Sep 228-573
30 Jun 228-473
31 Mar 228-363
31 Dec 218-262
30 Sep 218-261
30 Jun 218-161
31 Mar 217-151
31 Dec 207-262
30 Sep 207-362
30 Jun 207-471
31 Mar 208-692
31 Dec 199-4112
30 Sep 1911-6133
30 Jun 1913-3144
31 Mar 19141154
31 Dec 18160155
30 Sep 18170164
30 Jun 1817-7174
31 Mar 1818-11173
31 Dec 1717-20173
30 Sep 1716-20173
30 Jun 1716-17173
31 Mar 1714-38164
31 Dec 1612-35164
30 Sep 1611-43164
30 Jun 1610-42154
31 Mar 168-23143
31 Dec 157-21133
30 Sep 156-13123
30 Jun 155-11113
31 Mar 155-12103
31 Dec 146-1183
30 Sep 146-1273
30 Jun 145-1173
31 Mar 145-872
31 Dec 135-983

質の高い収益: NLZ0 is currently unprofitable.

利益率の向上: NLZ0 is currently unprofitable.


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: NLZ0 is unprofitable, and losses have increased over the past 5 years at a rate of 16.3% per year.

成長の加速: Unable to compare NLZ0's earnings growth over the past year to its 5-year average as it is currently unprofitable

収益対業界: NLZ0 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).


株主資本利益率

高いROE: NLZ0 has a negative Return on Equity (-45.84%), as it is currently unprofitable.


総資産利益率


使用総資本利益率


過去の好業績企業の発掘